Holen Sie sich die Stockscreener-App
238.81
0.71%
1.69
Schlusskurs vom Vortag:
$237.12
Offen:
$236.99
24-Stunden-Volumen:
500.61K
Relative Volume:
0.39
Marktkapitalisierung:
$32.96B
Einnahmen:
$1.96B
Nettoeinkommen (Verlust:
$-253.24M
KGV:
-125.61
EPS:
-1.9012
Netto-Cashflow:
$94.06M
1W Leistung:
+3.55%
1M Leistung:
+25.97%
6M Leistung:
+48.14%
1J Leistung:
+41.77%
1-Tages-Spanne:
$235.77
$239.76
1-Wochen-Bereich:
$227.71
$241.28
52-Wochen-Spanne:
$125.38
$241.28
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
238.81 | 32.73B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
590.83 | 222.89B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.78 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.88 | 60.36B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.50 | 43.70B | 6.95B | 1.30B | 1.09B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
230.01 | 39.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera director Botha sells $17.7 million in stock By Investing.com - Investing.com Australia
Assessing Natera’s Value After 47.6% Rally and New Partnerships in 2025 - Yahoo Finance
Natera director Botha sells $17.7 million in stock - Investing.com
Will Flatiron Partnership Give Natera (NTRA) a New Edge in OncoEMR Integration? - simplywall.st
Natera stock hits all-time high at 240.96 USD By Investing.com - Investing.com Canada
Natera stock hits all-time high at 240.96 USD - Investing.com
Key facts: JP Morgan raises Natera target; shares rise 2.9%; BV369 Trust to sell 75,000 shares - TradingView
JP Morgan Raises Price Target for Natera (NTRA) to $250 | NTRA S - GuruFocus
Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know - The Globe and Mail
Natera (NTRA): Evaluating Valuation After Q3 Growth, Analyst Upgrades, and OncoEMR Integration - simplywall.st
Natera co-founder Sheena Jonathan sells $3.17 million in stock By Investing.com - Investing.com Nigeria
Natera director Baynes sells $2.8 million in shares By Investing.com - Investing.com Canada
Natera co-founder Sheena Jonathan sells $3.17 million in stock - Investing.com
Natera director Baynes sells $2.8 million in shares - Investing.com
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know - Finviz
Natera Inc. (NTRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Week of July 2026 Options Trading For Natera (NTRA) - Nasdaq
Will Natera Inc. stock attract ESG investorsTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Trade Tracker: Stephanie Link buys Natera - MSN
Is Natera Inc. stock positioned for digital transformationTrade Risk Report & AI Driven Stock Reports - newser.com
Spotting Winners: Natera (NASDAQ:NTRA) And Immuno-Oncology Stocks In Q3 - Finviz
Can Natera Inc. stock withstand economic slowdown2025 Biggest Moves & Community Consensus Picks - newser.com
Is Flatiron Health Integration Expanding Natera's Market Opportunity and Investment Narrative for NTRA? - Yahoo Finance
Natera at Wolfe Conference: Strategic Growth and Innovation - Investing.com
How to integrate Natera Inc. into portfolio analysis tools2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Employees Volunteer Over 1,500 Hours During Natera's Annual Volunteer Month - Lelezard
Will Natera Inc. stock beat EPS estimatesPortfolio Gains Summary & Community Consensus Picks - newser.com
Transcript : Natera, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 01 - MarketScreener
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):